换一批CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.
第一作者：
Meredith M,Regan
第一单位：
IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
作者：
医学主题词
老年人(Aged);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);芳香酶抑制剂(Aromatase Inhibitors);乳腺肿瘤(Breast Neoplasms);细胞色素P450 CYP2D6(Cytochrome P-450 CYP2D6);无病生存(Disease-Free Survival);用药计划表(Drug Administration Schedule);女(雌)性(Female);基因型(Genotype);人类(Humans);国际合作(International Cooperation);Kaplan-Meiers评估(Kaplan-Meier Estimate);中年人(Middle Aged);腈类(Nitriles);聚合酶链反应(Polymerase Chain Reaction);多态现象, 遗传(Polymorphism, Genetic);多态性, 单核苷酸(Polymorphism, Single Nucleotide);绝经后期(Postmenopause);他莫昔芬(Tamoxifen);治疗结果(Treatment Outcome);三唑类(Triazoles)
DOI
10.1093/jnci/djs125
PMID
22395644
发布时间
2022-03-10
- 浏览54
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
